Kinlytic Purple Book BLA 021846

BLA number
021846
Proprietary names
Kinlytic
Proper names
urokinase
Applicant
Microbix Biosystems Inc.
Center
CDER
First observed release
2020-05-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001Kinlyticurokinase351(a)250,000IUFor InjectionIntravenousSingle-Dose VialDiscLicensed1978-01-16
002Kinlyticurokinase351(a)9,000IUFor InjectionIntravenousSingle-Dose VialDiscLicensed1978-01-16
003Kinlyticurokinase351(a)5,000IUFor InjectionIntravenousSingle-Dose VialDiscLicensed1978-01-16

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2020-05-01R001Kinlytic351(a)DiscMicrobix Biosystems Inc.
2020-05-01R002Kinlytic351(a)DiscMicrobix Biosystems Inc.
2020-05-01R003Kinlytic351(a)DiscMicrobix Biosystems Inc.

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2020-05-01001Kinlytic351(a)DiscLicensed1978-01-16
2020-05-01002Kinlytic351(a)DiscLicensed1978-01-16
2020-05-01003Kinlytic351(a)DiscLicensed1978-01-16